SUPERSTRAIN DDS®-1
Lactobacillus acidophilus
Our trademarked superstrain Lactobacillus acidophilus DDS®-1, is one of the longest studied probiotic strains with over 35 years of clinical research. In addition to longevity, DDS®-1 is:
- One of the few probiotic strains clinically shown to be well-tolerated in virtually all age groups
- Clinically proven to support digestive and immune health
- Clinically shown to be supportive of digestive functions through the hydrolysis of milk proteins and lactose
- Well-established in the manufacturing of yogurt, fermented dairy products and probiotic supplements
- Able to produce an important antibacterial compound called “acidophilin” that can inhibit the growth of pathogens, such as E. coli, S. aureus, Salmonella spp., etc. which improves its potential to beneficially modulate the microflora
- Very acid-resistant and shown to tolerate harsh conditions such as acid, bile and oxygen which are encountered in the human gastrointestinal tract
- Shown to have excellent adherence to human intestinal cell lines in vitro which improves its potential in the human gut and provides a better opportunity for the probiotic to exert its beneficial properties
- Continuously studied either alone or in combination with other probiotic strains through the use of gold-standard randomized, double-blind, placebo-controlled clinical trials
The History of Probiotic Superstrain DDS ®-1
As one of the most influential probiotics scientists to date, Dr. Khem Shahani began his landmark research on L. acidophilus at the University of Nebraska in the late 1950’s. There he discovered a particular strain of L. acidophilus that showed superior growth, stability and nutritional potential. Dr. Shahani would spend the rest of his career unlocking the strain’s potential for improving overall health. During his lengthy career, the late Dr. Shahani had over 200 articles published in peer-reviewed scientific journals and was a consultant for international agencies such as the World Health Organization.
